Stem Cell Therapy for...
FPN Logo
Upgrade   |    Donate Now   |     |   Support Groups  |   Contact Us
October 2016
Stem Cell Therapy for Neuropathic Pain: New Findings Show Promise
Stem Cell Therapy 
Stem cell research at Cleveland Clinic could pave the way for an entirely new approach to chronic pain treatment that reduces medicine's current reliance on opioid therapy for intractable pain. Although many questions must be answered before it can be known whether stem cell therapy is safe and effective for humans, some small patient studies show potential. Read more! 
Treating Painful Diabetic Peripheral Neuropathy: An Update
Neuropathy Action Foundation Announces Results from Multifocal Motor Neuropathy (MMN) Survey
FPn Neuropathy Action Foundation
The Neuropathy Action Foundation (NAF) announced the results from the first ever international Multifocal Motor Neuropathy (MMN) Quality of Life (QOL) Patient Survey. The survey focused on three primary areas: timely and accurate diagnosis, efficacy of treatment, and the impact of the disease on patient's quality of life. The NAF believes these survey results will increase awareness and action among researchers, providers, the general public and public policy officials. Read more!
Mindfulness Meditation Uses Distinct Neural Pathways to Reduce Pain Better Than Placebo
Mindfulness Meditation
Recent research showed that mindfulness meditation is significantly more effective at reducing pain intensity and pain unpleasantness than placebo analgesia, sham mindfulness meditation and other cognitive-based approaches by using distinct neural mechanisms. Read more! 
FDA Incentivizing Pharma to Develop Less Abusable Pain Medicines
FDA Incentivizing Pahrma
With opioid abuse and misuse continuing to be a public health problem in the U.S., there is an urgent need for balanced, commonsense solutions to address this ongoing public health problem without abandoning those who legitimately need pain relief. One important approach is creating medicines that provide pain relief while reducing the potential for abuse. FDA has been instrumental in supporting the development of abuse deterrent medicines at the same time that many science-based research and development companies are investing in such innovations. Read more!  


Like us on Facebook 
The Foundation for Peripheral Neuropathy (FPN) is excited to participate this year in the international movement dedicated to giving and sharing called #GivingTuesday.  Watch for upcoming announcements on how you can support FPN on #GivingTuesday by helping us build awareness and give hope.
FPN Giving Tuesday Donate 
Looking for more access?  More information? PREMIUM Members of the Foundation for Peripheral Neuropathy get the latest peripheral neuropathy information and exclusive access to valuable resources while supporting the cause.  If you have not yet joined it's easy to do so!
If you're already a member thank you!! 
Donate
Click here to Donate!

Disclaimer: The information contained in this e-news is not intended to substitute for informed medical advice. You should not use this information to diagnose or treat a health problem or disease without consulting a qualified health care provider. You are strongly encouraged to consult a neurologist with any questions or comments you may have regarding your condition. The best care can only be given by a qualified provider who knows you personally.
By clicking "unsubscribe" below, you will no longer receive ANY communication from the Foundation.  If you prefer to stop receiving our
monthly E-News please contact us at info@tffpn.org to be removed from this list.